Thinking of joining a study?

Register your interest

Become a volunteer?

NCT07291154 | RECRUITING | End Stage Renal Disease (ESRD)

Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy
Sponsor:

Y UN Feng X IA

Information provided by (Responsible Party):

Y UN Feng X IA

Brief Summary:

Many maintenance hemodialysis (MHD) patients develop negative outlooks due to their illnesses and complications, making their quality of life and prognosis a clinical concern. Effective life management and treatment cooperation are crucial to improving dialysis quality and patient outcomes. This trial aims to evaluate whether management through the "Yueya" mini-program and WeChat can provide personalized guidance such as health education, diet, exercise, medication supervision, and condition monitoring to enhance treatment compliance, quality of life, strengthen quality control in the hemodialysis unit, and improve patient prognosis. Patients will be divided into a group receiving support via the "Yueya" mini-program and WeChat, and a control group receiving routine care. Clinical and laboratory indicators, cardiovascular events, death, hospitalization, quality of life, and compliance will be recorded and compared between groups to assess the impact of APP-assisted patient management on the quality of MHD blood purification therapy and the prognosis of MHD patients.

Condition or disease

End Stage Renal Disease (ESRD)

Maintenance Hemodialysis

Intervention/treatment

APP-based management

Phase

NA

Detailed Description:

Affected by their own diseases and various complications, many maintenance hemodialysis (MHD) patients have a negative and pessimistic attitude toward life. Their quality of life and prognosis have always been a concern for clinicians. Therefore, how to adjust and manage the lives of these patients, enable them to actively cooperate with various treatment methods, maximize the quality of blood purification therapy, and improve their quality of life and prognosis has become an extremely important research topic.

Study Type : INTERVENTIONAL
Estimated Enrollment : 392 participants
Masking : NONE
Primary Purpose : HEALTH_SERVICES_RESEARCH
Official Title : Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy
Actual Study Start Date : 2025-09-22
Estimated Primary Completion Date : 2026-12-31
Estimated Study Completion Date : 2026-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 75 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Patients with stage 5 chronic kidney disease, who have received maintenance hemodialysis for more than 3 months, are aged between 18 and 75 years old, and have regular dialysis three times a week.
  • * Patients with relatively stable condition, who are able to take care of themselves and willing to cooperate with the study.
  • * Patients who can understand and proficiently use WeChat and the "Yueya" mini - program used in this study.
Exclusion Criteria
  • * Patients with communication barriers or other conditions that prevent them from cooperating with the study.
  • * Patients who have a history of acute myocardial infarction, cerebral infarction or intracerebral hemorrhage in the past six months.
  • * Patients who are not willing to actively cooperate with the study.
  • * Patients with severe liver cirrhosis, active tuberculosis and AIDS.
Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy

Location Details

NCT07291154

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

China, Chongqing Municipality

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China, 400016